Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

Richard D. Moore; Kelly A. Gebo; Gregory M. Lucas; Jeanne C. Keruly

doi:10.1086/592115

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

Richard D. Moore, Kelly A. Gebo, Gregory M. Lucas, Jeanne C. Keruly

School of Medicine

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

The rate of comorbidities not related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) among HIV-infected patients may be higher than expected. We assessed the incidence of comorbidities not related to HIV infection or AIDS by CD4 cell count and highly active antiretroviral therapy (HAART) use status in an HIV clinical practice. A total of 2824 patients contributed 9172 person-years of longitudinal data during the period 1997-2006. Among patients with a CD4 cell count <350 cells/mm ³, receipt of HAART was associated with a significantly decreased incidence of comorbidities not related to HIV infection or AIDS.

Original language	English (US)
Pages (from-to)	1102-1104
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	47
Issue number	8
DOIs	https://doi.org/10.1086/592115
State	Published - Oct 15 2008

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/592115

Cite this

@article{d699f00879124fa0903c37be701fc2a5,

title = "Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status",

abstract = "The rate of comorbidities not related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) among HIV-infected patients may be higher than expected. We assessed the incidence of comorbidities not related to HIV infection or AIDS by CD4 cell count and highly active antiretroviral therapy (HAART) use status in an HIV clinical practice. A total of 2824 patients contributed 9172 person-years of longitudinal data during the period 1997-2006. Among patients with a CD4 cell count <350 cells/mm 3, receipt of HAART was associated with a significantly decreased incidence of comorbidities not related to HIV infection or AIDS.",

author = "Moore, {Richard D.} and Gebo, {Kelly A.} and Lucas, {Gregory M.} and Keruly, {Jeanne C.}",

note = "Funding Information: Potential conflicts of interest. R.D.M. has been a consultant for Bristol-Myers Squibb and has received research funding from Merck, Pfizer, and Gilead. All other authors: no conflicts.",

year = "2008",

month = oct,

day = "15",

doi = "10.1086/592115",

language = "English (US)",

volume = "47",

pages = "1102--1104",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

AU - Moore, Richard D.

AU - Gebo, Kelly A.

AU - Lucas, Gregory M.

AU - Keruly, Jeanne C.

N1 - Funding Information: Potential conflicts of interest. R.D.M. has been a consultant for Bristol-Myers Squibb and has received research funding from Merck, Pfizer, and Gilead. All other authors: no conflicts.

PY - 2008/10/15

Y1 - 2008/10/15

N2 - The rate of comorbidities not related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) among HIV-infected patients may be higher than expected. We assessed the incidence of comorbidities not related to HIV infection or AIDS by CD4 cell count and highly active antiretroviral therapy (HAART) use status in an HIV clinical practice. A total of 2824 patients contributed 9172 person-years of longitudinal data during the period 1997-2006. Among patients with a CD4 cell count <350 cells/mm 3, receipt of HAART was associated with a significantly decreased incidence of comorbidities not related to HIV infection or AIDS.

AB - The rate of comorbidities not related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) among HIV-infected patients may be higher than expected. We assessed the incidence of comorbidities not related to HIV infection or AIDS by CD4 cell count and highly active antiretroviral therapy (HAART) use status in an HIV clinical practice. A total of 2824 patients contributed 9172 person-years of longitudinal data during the period 1997-2006. Among patients with a CD4 cell count <350 cells/mm 3, receipt of HAART was associated with a significantly decreased incidence of comorbidities not related to HIV infection or AIDS.

UR - http://www.scopus.com/inward/record.url?scp=53349144166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53349144166&partnerID=8YFLogxK

U2 - 10.1086/592115

DO - 10.1086/592115

M3 - Article

C2 - 18781885

AN - SCOPUS:53349144166

SN - 1058-4838

VL - 47

SP - 1102

EP - 1104

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 8

ER -

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this